Related Experiment Videos
CBP truncating mutations in ovarian cancer
Journal of Medical Genetics
|June 7, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Association of gene variant type and location with breast cancer risk in the general population.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
British journal of cancer·2014
CACNA1C variants associated with focal epilepsy and their correlations with arrhythmias and developmental disorders.
Journal of medical genetics·2026
Enrichment of an Ehlers-Danlos-like phenotype in women with the FMR1 premutation: a pilot study.
Journal of medical genetics·2026
Single-cell transcriptomics identifies neural fate disruption and glial reprogramming caused by RARS2 deficiency.
Journal of medical genetics·2026
Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making.
Journal of medical genetics·2026
Circadian Rhythms in Colorectal Cancer: Recent Advances in Development and Treatment.
Journal of clinical medicine research·2026
Microbiome-Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response.
BioMed research international·2026